INSIGHTS ON PHARMACEUTICAL PRODUCTION
-
Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing
See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.
-
Tackling Encapsidated Host Cell DNA To Improve Quality
Discover a cell line that enhances rAAV production by reducing host cell DNA encapsidation, improving safety and efficiency through genetic modifications that inhibit apoptotic DNA fragmentation.
-
Sterilizing Filtration During Small Molecule Drug Formulation And Filling
Sterile drug production relies on both prevention and remediation of contamination. A multi-stage filtration strategy reduces microbial load, protects critical filters from fouling, and ensures consistent product quality, process efficiency, and patient safety.
-
Powering The Next Generation Of Drug Delivery Systems
Discover how pharmaceutical extrusion, including aseptic methods, enables advanced drug delivery systems, detailing the critical process controls required for success with complex and novel drug products.
-
What Is Drug Antibody Ratio (DAR) And How It Relates To Biotherapeutics?7/13/2026
DAR is a key quality attribute that shapes ADC potency, safety, stability, and developability. Learn why accurate measurement and control are essential as ADC pipelines expand and expectations rise.
-
Increasing Batch Size And Reducing Cycle Times For A Biologic8/5/2025
JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.
-
Delivering Simplicity Without Compromise7/2/2026
Optimize biopharma drug delivery with a flexible platform adapting to multiple syringe formats. Streamline manufacturing, secure dual-source supply, and encourage patient independence.
-
Navigating Shifts In Supply Chain And Manufacturing9/23/2026
As development demands grow, success depends on flexibility and resilience. Learn how manufacturers are adapting to meet new challenges.
-
Scaling Cation Exchange And Affinity Chromatography Operations8/20/2026
See how consistent residence time, linear velocity, and gradient formation support predictable monoclonal antibody purification across column scales while preserving chromatographic performance.
PHARMACEUTICAL PRODUCTION SOLUTIONS
-
In therapeutic development and manufacturing, employing a stringent risk mitigation plan for early detection of mycoplasmas is important to avoid costly manufacturing delays or remediation activities.
-
As a dedicated center of excellence in this product family, we offer a high degree of versatility and tailored solutions to meet the specific needs of each client.
-
Recent years have shown steady growth in manufacturing sterile, high potent products in the pharmaceutical industry. Antibiotics for intravenous or intramuscular injection in powder form such as Ceftriaxone Sodium for example, need to be produced under sterile conditions.
-
Batch manufacturing is still commonplace in the pharmaceutical and chemical industry. Such operations require to use intermediate packaging for product storage between each process step leading to numerous disadvantages such as low production flexibility, process downtime, high risks of operator exposure, product contamination and sterility loss.
-
AustinPx offers integrated GMP manufacturing services for oral dosage forms with a full complement of analytical development and testing capabilities.